PHATHOM PHARMACEUTICALS, INC. (PHAT) Net income 2018–2025
PHATHOM PHARMACEUTICALS, INC. (PHAT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$221,250FY2025 · since FY2018: -$1.3M → -$221,250
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$221,250 | +33.8% |
| FY2024 | -$334,330 | -65.8% |
| FY2023 | -$201,590 | +99.9% |
| FY2022 | -$197.7M | -37.4% |
| FY2021 | -$143.9M | -11.5% |
| FY2020 | -$129.1M | +49.4% |
| FY2019 | -$255.1M | -19708.3% |
| FY2018 | -$1.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice